0001179110-21-008895.txt : 20210922
0001179110-21-008895.hdr.sgml : 20210922
20210922180828
ACCESSION NUMBER: 0001179110-21-008895
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210921
FILED AS OF DATE: 20210922
DATE AS OF CHANGE: 20210922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Veness Adam M
CENTRAL INDEX KEY: 0001778623
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36065
FILM NUMBER: 211270450
MAIL ADDRESS:
STREET 1: C/O ACCELERON PHARMA INC.
STREET 2: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACCELERON PHARMA INC
CENTRAL INDEX KEY: 0001280600
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-9200
MAIL ADDRESS:
STREET 1: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2021-09-21
0
0001280600
ACCELERON PHARMA INC
XLRN
0001778623
Veness Adam M
128 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
SVP, General Counsel and Sec.
Common Stock
2021-09-21
4
M
0
5200
30.17
A
24123
D
Common Stock
2021-09-21
4
M
0
1450
41.20
A
25573
D
Common Stock
2021-09-21
4
S
0
6650
150.05
D
18923
D
Option to Purchase Common Stock
30.17
2021-09-21
4
M
0
5200
0
D
2027-03-02
Common Stock
5200
0
D
Option to Purchase Common Stock
41.20
2021-09-21
4
M
0
1450
0
D
2025-01-08
Common Stock
1450
0
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.36 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
The shares of common stock underlying this stock option award vested in equal quarterly installments over the four years after January 1, 2017.
The shares of common stock underlying this stock option award vested in equal quarterly installments over the four years after January 1, 2015.
/s/ Adam M. Veness
2021-09-22